Cognizant Technology Solutions CTSH benefits from an expanding portfolio with the recent launch of Neuro Edge, a new platform in its Neuro suite. The solution empowers businesses across industries to harness the power of edge AI, enabling real-time decision-making and operational efficiency while reducing dependency on centralized servers and the cloud. Neuro Edge supports a hybrid Cloud + Edge AI approach, ensuring data privacy, security and seamless integration with existing IT environments. With applications spanning healthcare, manufacturing, retail, automotive and more, Cognizant is poised to transform enterprise capabilities in AI-driven edge computing. Cognizant’s Prospects Driven by Strong Partner Base The latest move bodes well with CTSH’s focus on enhancing AI capabilities and providing industry-specific solutions through the Cognizant Neuro Edge platform. Further expanding its portfolio, Cognizant recently announced an agreement with Texas Dow Employees Credit Union (TDECU) to leverage its AI-driven Neuro IT Operations platform for enhancing operational efficiency, resilience and customer experience in TDECU’s transformation journey. Cognizant’s robust partner base, which includes the likes of Gentherm THRM, Microsoft MSFT and CNO Financial Group CNO, is a critical catalyst. Its robust pipeline, which includes a favorable mix of new opportunities, is noteworthy. In first-quarter 2024, CTSH demonstrated significant improvement in securing large deals, winning several contracts worth more than $100 million each. The company recently collaborated with Gentherm to provide engineering services, including systems engineering, validation and model-based development, aiming to enhance agility and scalability in product development through cloud-native technologies and virtualization. In April, Cognizant, in collaboration with Microsoft, announced an expanded partnership aiming to leverage generative AI and Copilots to drive innovation across industries, focusing on transforming enterprise operations and enhancing employee experiences. In first-quarter 2024 Cognizant announced the continuation of its partnership with CNO Financial, a leading provider of insurance, financial services, and workforce benefits solutions to middle-income America. Cognizant will help in optimizing and enhancing CNO Financials’ technology-based services and solutions with cloud and digital technologies. Conclusion Despite an expanding portfolio and a strong partner base, weakness in the Financial Services segment negatively impacted Cognizant’s top line. In first-quarter 2024, revenues of $4.76 billion saw a year-over-year decline of 1.1% and 1.2% at constant currency (cc). The Financial Services revenues dropped 6.2% year over year to $1.38 billion during this period. The company’s shares have declined 10.3% against the Zacks Computer & Technology sector’s growth of 24.5% year to date. This Zacks Rank #2 (Buy) company expects second-quarter 2024 revenues to be between $4.75 billion and $4.82 billion, indicating a decline of 2.9% to 1.4% (a decline of 2.5-1% at cc). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. The Zacks Consensus Estimate for second-quarter revenues is pegged at $4.81 billion, indicating a decline of 1.63% from year-ago levels. The consensus mark for earnings is pegged at $1.12 per share, unchanged in the past 30 days. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Microsoft Corporation (MSFT):Free Stock Analysis Report Cognizant Technology Solutions Corporation (CTSH):Free Stock Analysis Report CNO Financial Group, Inc. (CNO):Free Stock Analysis Report Gentherm Inc (THRM):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Cognizant (CTSH) Expands Neuro Suite With Edge AI Platform
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...